Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Phase IV Clinical Trial to Describe the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

NCT03856619 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03856619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03856619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Phase IV Clinical Trial to Describe the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
March 27, 2019
Completion date
May 13, 2022
Enrollment
121 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing multiple sclerosis